Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1995-07-19
1997-01-21
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
514492, A61K 3324, A61K 3128
Patent
active
055957633
ABSTRACT:
The pharmaceutical composition contains an effective amount of a tungsten (VI) compound, preferably a tungstate or a isopolytungstate, and more preferably sodium tungstate. In the method of lowering blood sugar in a human suffering from type I or type II diabetes mellitus, an effective amount of the composition is administered orally. Compared with the known vanadium compositions, the invention has the advantage of providing a similar high sugar-lowering activity but with a much lower oral toxicity at effective doses, both short- and long-term. Compared with insulin, the invention does not present the adverse effect of inducing hypoglycemia when administered in excess.
REFERENCES:
patent: 4746504 (1988-05-01), Nimrod et al.
patent: 4851430 (1989-07-01), Kopf-Maier et al.
patent: 4882171 (1989-11-01), Posner et al.
patent: 5374537 (1994-12-01), Orlando et al.
Insulin-Like Action of Tungstate in Diabetic Rats, Albert Barbera, et al, Aug. 5, 1994, Journal of Biological Chemistry, vol. 269, No. 31.
Diabetes, vol. 43, Oct. 1994, "Reply to Domingo, et al and McNeill, et al".
Encyclopedia of Chemical Technology, 3rd Edition, vol. 23, Kirk Othmer "Tungsten Compounds", pp. 426, 435 & 438, 1983.
Toxicology, 66 (1991), pp. 279-287, J. L. Domingo, et al, "Oral Vanadium Administration to Streptozotocindiabetic Rats . . . ".
Endeavour, New Series, vol. 17, No. 1, 1993, Schechter, et al, "Vanadium Salts and the Future Treatment of Diabetes".
Archives of Biochemistry and Biophysics, vol. 301, No. 2, 1993, pp. 411-415, Joan Enric Rodriguez-Gil, et al.
Diabetes, vol. 40, Dec. 1991, pp. 1675-1678, McNeill, et al, "Insulinlike Effects of Sodium Selenate in Streptozocin-Induced Diabetic Rats".
Science, vol. 227, pp. 1474-1477, Heyliger, et al, "Effect of Vanadate on Elevated Blood Glucose and Depressed Cardiac Performance of Diabetic Rats" (1985).
Barbera Albert
Guinovart Joan J.
Rodriguez-Gil Joan E.
Henley III Raymond
Quimica Farmaceutica Bayer S.A.
Striker Michael J.
LandOfFree
Tungsten (VI) compositions for the oral treatment of diabetes me does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tungsten (VI) compositions for the oral treatment of diabetes me, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tungsten (VI) compositions for the oral treatment of diabetes me will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2322557